Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

PAC1

SKU: orb1225331

Description

PAC-1 is a potent procaspase-3 activator with EC50 of 0.22 μM and the first small molecule known to directly activate procaspase-3 to caspase-3.(In Vitro):PAC-1 activates procaspase-3 with an EC50 of 2.08 μM. PAC-1 exhibits an enhanced zinc chelating ability (EC50= 7.08 μM). PAC-1 induces leukemia cell death with IC50 of 4.03 μM, which is consistent with the values reported by other investigators. PAC-1 treatment also results in death of other malignant cells in a concentration-dependent manner with IC50s ranging from 4.03 to 53.44μM. The overall mean IC50 in the fifteen malignant cell lines is 0.88 mM for WF-210 and 19.40 μM for PAC-1. In contrast, the sensitivity of the normal human cells (PBL, L-02, HUVEC and MCF 10A) to WF-210 is 2.6-fold lower (mean IC50=412.34 μM) than PAC-1 (mean IC50=158.29 μM). Procaspase-activating compound-1 (PAC-1) is the first direct caspase-activating compound discovered. PAC-1 treatment upregulates Ero1α in multiple cell lines, whereas silencing of Ero1α significantly inhibits calcium release from ER and cell death.\n(In Vivo):To evaluate the in vivo effect of WF-210 on the growth of malignant tumors, we examined the ability of WF-210 to suppress tumor growth in mouse Hep3B and MDA-MB-435 xenograft models. These two cell lines express procaspase-3 at relatively high levels. Tumors induced by xenografts of the liver cancer cell Hep3B are allowed to develop and grow to a size of 100 mm3, after which WF-210 (2.5 mg/kg) or PAC-1 (5.0 mg/kg) is given daily for two weeks by intravenous (i.v.) administration. As shown in both PAC-1 and WF-210 significantly inhibits the growth of Hep3B tumor xenografts.

Images & Validation

Key Properties

CAS Number315183-21-2
MW392.49
Purity>98% (HPLC)
FormulaC23H28N4O2
SMILESO=C(N/N=C/C1=CC=CC(CC=C)=C1O)CN2CCN(CC3=CC=CC=C3)CC2
TargetCaspase
SolubilityEthanol: 16 mg/mL (40.76 mM); DMSO: 78 mg/mL (198.73 mM)

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Procaspase-activating Compound 1

Similar Products

  • Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor 1 (PACAPR) ELISA Kit [orb1949199]

    Human

    0.16-10ng/mL

    0.1 ng/mL

    48 T, 96 T
  • Mouse Pituitary Adenylate Cyclase Activating Polypeptide Receptor 1 (PACAPR1) ELISA Kit [orb1949198]

    Mouse

    0.16-10ng/mL

    0.1 ng/mL

    48 T, 96 T
  • PSMG1 Rabbit Polyclonal Antibody [orb312514]

    IF,  IHC-Fr,  IHC-P,  WB

    Mouse

    Human, Mouse

    Rabbit

    Polyclonal

    Unconjugated

    50 μl, 100 μl, 200 μl
  • KLF6 Rabbit Polyclonal Antibody [orb10959]

    IF,  IHC-Fr,  IHC-P,  WB

    Bovine, Equine, Gallus, Porcine, Rabbit

    Human, Mouse, Rat

    Rabbit

    Polyclonal

    Unconjugated

    50 μl, 100 μl, 200 μl
  • Recombinant Human ADCYAP1R1 N-ECD Protein [orb2992729]

    SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)

    Predicted: 16.7 KDa. Observed: 24- 40 KDa, reducing conditions

    10 μg, 50 μg, 500 μg, 1 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

5 mg
$ 70.00
10 mg
$ 90.00
25 mg
$ 140.00
50 mg
$ 210.00
100 mg
$ 370.00
500 mg
$ 1,410.00